BG Medicine, Inc. (BGMD) said Thursday that it has appointed Charles Abdalian, Jr., as Executive Vice President, Chief Financial Officer.
Abdalian most recently held the position of Vice President and Chief Financial Officer of Knome, Inc., a bioinformatics company providing human genome interpretation software and services to international bio/pharma companies, leading academic institutions and molecular diagnostics labs.
Prior to Knome, Abdalian was Senior Vice President and Chief Financial Officer of Molecular Insight Pharmaceuticals, a publically traded radiopharmaceuticals company.
Michael Rogers, who has served as CFO of BG Medicine during the past three and half years, will be leaving the company.
For comments and feedback contact: editorial@rttnews.com
Business News